Π ΠΠ ΠΈ Π½Π΅ΡΡΡΡΠΊΡΡΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ NS4 Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° C Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ C
ΠΠ»Ρ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ Π² ΠΏΠΎΠ΄Π°Π²Π»ΡΡΡΠ΅ΠΌ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΡΠ»ΡΡΠ°Π΅Π² Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΠΎ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅. Π‘ΡΠΈΡΠ°Π΅ΡΡΡ, ΡΡΠΎ Π½Π° ΠΎΠ΄ΠΈΠ½ ΡΠ»ΡΡΠ°ΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Ρ ΠΆΠ΅Π»ΡΡΡ ΠΎΠΉ ΠΏΡΠΈΡ ΠΎΠ΄ΠΈΡΡΡ, ΠΊΠ°ΠΊ ΠΌΠΈΠ½ΠΈΠΌΡΠΌ, ΠΏΡΡΡ-ΡΠ΅ΡΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π±Π΅Π·ΠΆΠ΅Π»ΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ°. Π 85% ΡΠ»ΡΡΠ°Π΅Π² Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΡΠ°ΠΊΠΆΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎΠΉ. ΠΡΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ ΡΠΈΡΠΎΠΊΠΎΠ΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΠ΅ ΠΠΠ‘-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π΄Π΅Π»Π°Π΅Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΡ ΡΡΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΠ‘ΠΠΠΠ¬ΠΠΠΠΠΠΠ«Π Π‘ΠΠΠ ΠΠ©ΠΠΠΠ―
- ΠΠΠΠΠΠΠΠ 6 ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«
- ΠΠ»Π°Π²Π° 1. ΠΠ±ΡΠΈΠ΅ ΡΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΎ Π²ΠΈΡΡΡΠ΅ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 1. 1. ΠΠΈΡΡΡ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ — ΡΡΡΠΎΠ΅Π½ΠΈΠ΅, ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ ΠΈ ΠΏΡΡΠΈ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΠΈ
- 1. 2. ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 1. 3. ΠΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΏΡΠΈ Π³Π΅ΠΏΠ°ΡΠΈΡΠ΅ Π‘
- ΠΠ»Π°Π²Π° 2. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 2. 1. ΠΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½ΠΎΠΌΠ°
- 2. 2. Π‘ΡΡΡΠΊΡΡΡΠ° ΠΈ ΡΡΠ½ΠΊΡΠΈΠΈ Π²ΠΈΡΡΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ²
- 2. 3. ΠΡΠΌΠΎΡΠ°Π»ΡΠ½ΡΠΉ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΠΈΠΌΠΌΡΠ½Π½ΡΠ΅ ΠΎΡΠ²Π΅ΡΡ ΠΏΡΠΈ ΠΠΠ‘-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ
- ΠΠ»Π°Π²Π° 3. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠ΅ ΠΎΡΠ½ΠΎΠ²Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 3. 1. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ Π±Π΅Π»ΠΊΠ°ΠΌ ΠΠΠ‘
- 3. 2. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ Π ΠΠ ΠΠΠ‘
- 3. 3. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π²ΠΈΡΡΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ²
- Π‘ΠΠΠ‘Π’ΠΠΠΠΠ«Π ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ― ΠΠΠ’ΠΠ ΠΠΠΠ« Π ΠΠΠ’ΠΠΠ«
- ΠΠ»Π°Π²Π° 4. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ
- ΠΠ»Π°Π²Π° 5. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ Π ΠΠ Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 5. 1. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ Π ΠΠ ΠΠΠ‘
- 5. 2. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ Π³Π΅Π½ΠΎΠΌΠ½ΠΎΠΉ Π ΠΠ ΠΠΠ‘
- 5. 3. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΡΠ΅ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠΎΡΠΌΡ Π ΠΠ Π²ΠΈΡΡΡΠ° 51 Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- ΠΠ»Π°Π²Π° 6. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΠΠ ΠΊ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠΌΡ Π±Π΅Π»ΠΊΡ NS Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 6. 1. Π Π΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ NS4 Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘
- 6. 2. Π‘ΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ΅ΡΠΈΠ΄Ρ
- 6. 3. ΠΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΡ
- 6. 4. ΠΠΈΠ΅Π»ΠΎΠΌΠ½Π°Ρ ΠΊΠ»Π΅ΡΠΎΡΠ½Π°Ρ Π»ΠΈΠ½ΠΈΡ
- 6. 5. ΠΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠ»Π΅ΡΠΎΠΊ
- 6. 6. Π‘Π»ΠΈΡΠ½ΠΈΠ΅ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈ Π²ΡΡΠ°ΡΠΈΠ²Π°Π½ΠΈΠ΅ Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌ
- 6. 7. Π‘ΠΊΡΠΈΠ½ΠΈΠ½Π³ Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌ
- 6. 8. ΠΡΠΈΠΎΠΊΠΎΠ½ΡΠ΅ΡΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌ
- 6. 9. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ Π°ΡΡΠΈΡΠ½ΡΡ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠ΅ΠΉ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ ΠΠΠ
- 6. 10. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΠΠ ΠΈΠ· Π°ΡΡΠΈΡΠ½ΡΡ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠ΅ΠΉ
- 6. 11. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π±Π΅Π»ΠΊΠ°
- 6. 12. Π‘ΡΠ±ΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΠΠ ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΈΠΏΠΎΠ² Π»Π΅Π³ΠΊΠΈΡ ΡΠ΅ΠΏΠ΅ΠΉ Π² ΡΠΎΡΡΠ°Π²Π΅ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½ΠΎΠ²
- 6. 13. Π’Π²Π΅ΡΠ΄ΠΎΡΠ°Π·Π½ΡΠΉ ΠΠ€Π
- 6. 14. ΠΠΌΠΌΡΠ½ΠΎΠ±Π»ΠΎΡ
- 6. 15. ΠΠΏΠΈΡΠΎΠΏΠ½ΠΎΠ΅ ΠΊΠ°ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΠΠ
- 6. 16. ΠΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠ½ΡΠΉ Ρ-ΠΠ€Π
- ΠΠ»Π°Π²Π° 7. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ Π±Π΅Π»ΠΊΠ° NS4 ΠΠΠ‘ in situ
- 7. 1. ΠΡΠΈΠ³ΠΎΡΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ
- 7. 2. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΡΠΈΠΎΡΡΠ°ΡΠ½ΡΡ ΡΡΠ΅Π·ΠΎΠ² ΠΏΠ΅ΡΠ΅Π½ΠΈ
- 7. 3. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² ΠΈΠ· ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ 59 7. 4. ΠΠ΅ΠΏΡΡΠΌΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· (Π½ΠΠ€) 59 7.5. ΠΠ΅ΠΏΡΡΠΌΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· in situ
- ΠΠ»Π°Π²Π° 8. Π‘ΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ²
- Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π« ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ
- ΠΠ»Π°Π²Π° 9. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π ΠΠ ΠΠΠ‘
- 9. 1. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π³Π΅Π½ΠΎΠΌΠ½ΠΎΠΉ Π ΠΠ ΠΠΠ‘
- 9. 2. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ ΠΌΠΈΠ½ΡΡ-Π ΠΠ ΠΠΠ‘
- 9. 3. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π ΠΠ ΠΠΠ‘ ΠΏΠΎΡΠ»Π΅ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ
- ΠΠ»Π°Π²Π° 10. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΠΠ
- 10. 1. Π‘Π»ΠΈΡΠ½ΠΈΠ΅ ΠΈ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³ Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌ
- 10. 2. Π₯Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΠΠ ΠΊ Π±Π΅Π»ΠΊΡ N84 71 10.3 .ΠΠΏΠΈΡΠΎΠΏΠ½Π°Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ ΠΠΠ 73 10.4. Π Π΅ΡΠΈΠΏΡΠΎΠΊΠ½ΡΠΉ ΠΊΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΠΠ
- ΠΠ»Π°Π²Π° 11. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π½Π°ΡΡΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° N84 ΠΠΠ‘
- 11. 1. ΠΠ΅ΡΠ΅ΠΊΡΠΈΡ N84 Π² ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠ°Ρ
- 11. 2. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π±Π΅Π»ΠΊΠ° N84 ΠΠΠ‘ Π½Π° ΠΊΡΠΈΠΎΡΡΠ°ΡΠ½ΡΡ ΡΡΠ΅Π·Π°Ρ ΠΏΠ΅ΡΠ΅Π½ΠΈ
- 11. 3. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π±Π΅Π»ΠΊΠ° N84 Π² Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ
- ΠΠΠ‘Π£ΠΠΠΠΠΠ Π ΠΠΠ£ΠΠ¬Π’ΠΠ’ΠΠ ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ
- ΠΠ«ΠΠΠΠ«
Π ΠΠ ΠΈ Π½Π΅ΡΡΡΡΠΊΡΡΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ NS4 Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° C Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ C (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
ΠΠΠ’Π£ΠΠΠ¬ΠΠΠ‘Π’Π¬ ΠΠ ΠΠΠΠΠΠ«.
ΠΠ΅ΠΏΠ°ΡΠΈΡ Π‘ ΡΠ²Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ. ΠΡΠΎ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½ΠΎ Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΈΠΌΠΈ ΠΏΡΠΈΡΠΈΠ½Π°ΠΌΠΈ. ΠΠΎ-ΠΏΠ΅ΡΠ²ΡΡ , Π²ΠΈΡΡΡ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ ΡΠΈΡΠΎΠΊΠΎ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ Π² ΠΌΠΈΡΠ΅, ΠΈΠΌ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½Ρ 170 ΠΌΠ»Π½ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ, ΡΡΠΎ ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΎΠΊΠΎΠ»ΠΎ 3% ΡΠ΅Π»ΠΎΠ²Π΅ΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ. ΠΠΎ-Π²ΡΠΎΡΡΡ , Π΄Π»Ρ Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠ΅Π½ Π²ΡΡΠΎΠΊΠΈΠΉ ΡΡΠΎΠ²Π΅Π½Ρ Ρ ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ. ΠΠΎ Π΄Π°Π½Π½ΡΠΌ ΡΠ°Π·Π½ΡΡ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠ², Π² 50 [17] - 85% [140] ΡΠ»ΡΡΠ°Π΅Π² ΠΎΡΡΡΡΠΉ Π³Π΅ΠΏΠ°ΡΠΈΡ Π‘ ΠΏΡΠΈΠ½ΠΈΠΌΠ°Π΅Ρ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅. Π 20−30% ΡΠ»ΡΡΠ°Π΅Π² Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π³Π΅ΠΏΠ°ΡΠΈΡ Π‘ Π·Π°ΠΊΠ°Π½ΡΠΈΠ²Π°Π΅ΡΡΡ ΡΠΈΡΡΠΎΠ·ΠΎΠΌ Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° ΠΏΠ΅ΡΠ΅Π½ΠΈ [180]. Π-ΡΡΠ΅ΡΡΠΈΡ , Π΄ΠΎ ΡΠΈΡ ΠΏΠΎΡ Π½Π΅ ΡΠΎΠ·Π΄Π°Π½ΠΎ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ΅Π΄ΡΡΠ² ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ³ΠΎ ΠΎΠΏΠ°ΡΠ½ΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ.
ΠΠ° Π΄ΠΎΠ»Ρ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ ΠΏΡΠΈΡ ΠΎΠ΄ΠΈΡΡΡ 20% ΡΠ»ΡΡΠ°Π΅Π² ΠΎΡΡΡΠΎΠ³ΠΎ ΠΈ 70% ΡΠ»ΡΡΠ°Π΅Π² Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° [26]. ΠΠ΅ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΈΡΡ ΠΎΠ΄Ρ ΠΏΡΠΈ ΠΎΡΡΡΠΎΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠ΅ Π‘ Π²ΡΡΡΠ΅ΡΠ°ΡΡΡΡ ΡΠ΅Π΄ΠΊΠΎ. ΠΠ΄Π½Π°ΠΊΠΎ, ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠ²ΡΠΎΠΏΠ΅ΠΉΡΠΊΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΈΡΠ΅ΡΠ° ΠΏΠΎ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ Π²ΠΈΡΡΡΠ½ΡΡ Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠ², Π³Π΅ΠΏΠ°ΡΠΈΡ Π‘ ΠΏΠΎ ΠΏΡΠΈΡΠΈΠ½Π΅ ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΠΈ ΡΡΠ΅Π΄ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ Π²ΡΠΎΡΠΎΠ΅ ΠΌΠ΅ΡΡΠΎ, ΡΡΡΡΠΏΠ°Ρ ΡΠΎΠ»ΡΠΊΠΎ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌΡ Π°Π»ΠΊΠΎΠ³ΠΎΠ»ΠΈΠ·ΠΌΡ [1].
ΠΠ»Ρ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ Π² ΠΏΠΎΠ΄Π°Π²Π»ΡΡΡΠ΅ΠΌ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΡΠ»ΡΡΠ°Π΅Π² Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΠΎ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅. Π‘ΡΠΈΡΠ°Π΅ΡΡΡ, ΡΡΠΎ Π½Π° ΠΎΠ΄ΠΈΠ½ ΡΠ»ΡΡΠ°ΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Ρ ΠΆΠ΅Π»ΡΡΡ ΠΎΠΉ ΠΏΡΠΈΡ ΠΎΠ΄ΠΈΡΡΡ, ΠΊΠ°ΠΊ ΠΌΠΈΠ½ΠΈΠΌΡΠΌ, ΠΏΡΡΡ-ΡΠ΅ΡΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π±Π΅Π·ΠΆΠ΅Π»ΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° [1]. Π 85% ΡΠ»ΡΡΠ°Π΅Π² Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΡΠ°ΠΊΠΆΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ Π±Π΅ΡΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΎΠΉ [26]. ΠΡΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ ΡΠΈΡΠΎΠΊΠΎΠ΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΠ΅ ΠΠΠ‘-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π΄Π΅Π»Π°Π΅Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΡ ΡΡΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ Π²ΠΎ Π²ΡΠ΅ΠΌ ΠΌΠΈΡΠ΅.
ΠΠ΅ΡΠ²ΠΈΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΠΠ‘-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈΠΈ ΠΎΡΠ½ΠΎΠ²ΡΠ²Π°Π΅ΡΡΡ Π½Π° Π²ΡΡΠ²Π»Π΅Π½ΠΈΠΈ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ Π²ΠΈΡΡΡΠ½ΡΠΌ Π±Π΅Π»ΠΊΠ°ΠΌ. ΠΡΠΈ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΠΈ ΡΡΠ²ΠΎΡΠΎΡΠΎΠΊ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊ ΠΠΠ‘, Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°ΡΡΠ΅Π³ΠΎ ΡΠ΅ΡΡΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΈΠΌΠΌΡΠ½ΠΎΠ±Π»ΠΎΡΡΠΈΠ½Π³Π°. ΠΠ΄Π½Π°ΠΊΠΎ Π΄Π»Ρ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΎΠ΄Π½ΠΈΡ Π²ΠΈΡΡΡΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ Π°Π½ΡΠΈΡΠ΅Π» Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ. ΠΡΠΎ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½ΠΎ ΡΡΠ΄ΠΎΠΌ ΠΏΡΠΈΡΠΈΠ½. ΠΠΎ-ΠΏΠ΅ΡΠ²ΡΡ , Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π°Π½ΡΠΈ-ΠΠΠ‘ Π°Π½ΡΠΈΡΠ΅Π» Π½Π΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠ°Π·Π³ΡΠ°Π½ΠΈΡΠΈΡΡ ΡΠ΅ΠΊΡΡΡΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΠΎΡ ΠΏΡΠΎΡΠ»ΠΎΠΉ, Π·Π°ΠΊΠΎΠ½ΡΠΈΠ²ΡΠ΅ΠΉΡΡ ΡΠ»ΠΈΠΌΠΈΠ½Π°ΡΠΈΠ΅ΠΉ Π²ΠΈΡΡΡΠ° [60]. ΠΠΎ-Π²ΡΠΎΡΡΡ , ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ° ΠΏΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ Π°Π½ΡΠΈΡΠ΅Π» Π½Π΅ Π²ΡΠ΅Π³Π΄Π° ΠΎΠ΄Π½ΠΎΠ·Π½Π°ΡΠ½ΠΎ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎΠ± ΠΎΡΡΡΡΡΡΠ²ΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π°Π³Π΅Π½ΡΠ° Π² ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅. ΠΡΠΎ ΡΠ²ΡΠ·Π°Π½ΠΎ Ρ Π½Π°Π»ΠΈΡΠΈΠ΅ΠΌ ΡΠ°ΠΊ Π½Π°Π·ΡΠ²Π°Π΅ΠΌΠΎΠ³ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° «ΠΎΠΊΠ½Π°» ΠΏΡΠΈ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΈ Π°Π½ΡΠΈΡΠ΅Π». ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, ΡΠ°ΡΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (ΠΎΠΊΠΎΠ»ΠΎ 10%), ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ ΠΏΡΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ΄ΠΈΡΠΈΡΠΈΡΠ½ΡΡ ΡΠΎΡΡΠΎΡΠ½ΠΈΡΡ , ΠΎΡΡΠ°Π΅ΡΡΡ ΡΠ΅ΡΠΎΠ½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠΉ [239]. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ Π²ΠΎΠ·Π½ΠΈΠΊΠ°Π΅Ρ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΡΡΠΌΡΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΈΡΡΡΠ° — Π ΠΠ ΠΈ Π±Π΅Π»ΠΊΠΎΠ². ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π ΠΠ ΠΠΠ‘ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ¦Π ΡΠ²Π»ΡΠ΅ΡΡΡ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π΅Π΄ΠΈΠ½ΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΡΠΌ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΡΠΌΠΎΠ³ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π²ΠΈΡΡΡΠ°. ΠΠ΄Π½Π°ΠΊΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π²ΠΈΡΡΡΠ½ΠΎΠΉ Π ΠΠ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ, Π³Π»Π°Π²Π½ΡΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ. Π ΡΠΎ Π²ΡΠ΅ΠΌΡ ΠΊΠ°ΠΊ ΠΏΠ΅ΡΠ΅Π½Ρ ΠΎΡΡΠ°Π΅ΡΡΡ Π½Π΅ΠΈΠ·ΡΡΠ΅Π½Π½ΠΎΠΉ. ΠΡΡΠ³ΠΈΠΌ ΠΏΡΡΠΌΡΠΌ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠΌ ΡΠ²Π»ΡΡΡΡΡ Π²ΠΈΡΡΡΠ½ΡΠ΅ Π±Π΅Π»ΠΊΠΈ, Π½ΠΎ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π΄ΠΎΡΡΡΠΏΠ½ΡΠ΅ ΡΠ΅ΡΡ-ΡΠΈΡΡΠ΅ΠΌΡ Π΄Π»Ρ ΠΈΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΎΡΡΡΡΡΡΠ²ΡΡΡ. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π ΠΠ ΠΈ Π±Π΅Π»ΠΊΠΎΠ² ΠΠΠ‘ Π½Π΅ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ — ΠΎΡΠ³Π°Π½Π΅, Π² ΠΊΠΎΡΠΎΡΠΎΠΌ ΠΏΡΠΎΠΈΡΡ ΠΎΠ΄ΠΈΡ Π°ΠΊΡΠΈΠ²Π½Π°Ρ ΡΠ΅ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΡ Π²ΠΈΡΡΡΠ° Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΠΊΠ°ΠΊ Π΄Π»Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π΄Π°Ρ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ, ΡΠ°ΠΊ ΠΈ ΡΡΠ΄Π° ΡΡΠ½Π΄Π°ΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ Π²ΠΈΡΡΡΠ° ΠΈ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘. ΠΠ½ΠΎΠ³ΠΈΠ΅ Π²ΠΎΠΏΡΠΎΡΡ, ΡΠ²ΡΠ·Π°Π½Π½ΡΠ΅ Ρ Π΄Π°Π½Π½ΡΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ΠΌ, ΠΎΡΡΠ°ΡΡΡΡ Π½Π΅ΡΠ΅ΡΠ΅Π½Π½ΡΠΌΠΈ. Π ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ, Π½Π΅ ΡΡΠ΅Π½ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΠΏΠ΅ΡΡΠΈΡΡΠ΅Π½ΡΠΈΠΈ Π²ΠΈΡΡΡΠ° ΠΈ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠ΅ΡΠ΅Π½ΠΈ [26]. ΠΠΊΡΠΈΠ²Π½ΠΎ ΠΎΠ±ΡΡΠΆΠ΄Π°Π΅ΡΡΡ ΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ΠΌ Π ΠΠ ΠΈ Π±Π΅Π»ΠΊΠΎΠ² Π²ΠΈΡΡΡΠ° ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°. ΠΡΠΊΡΡΡΡΠΌ ΠΎΡΡΠ°Π΅ΡΡΡ Π²ΠΎΠΏΡΠΎΡ ΠΎ Π²Π½Π΅ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΠΈ ΠΠΠ‘.
Π¦ΠΠΠ¬ Π ΠΠΠΠΠ§Π ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―
.
Π¦Π΅Π»Ρ Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΡ ΡΠΎΡΡΠΎΡΠ»Π° Π² ΠΈΠ·ΡΡΠ΅Π½ΠΈΠΈ ΡΠ°ΡΡΠΎΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π³Π΅Π½ΠΎΠΌΠ½ΠΎΠΉ ΠΈ Π°Π½ΡΠΈΠ³Π΅Π½ΠΎΠΌΠ½ΠΎΠΉ ΡΠΎΡΠΌ Π ΠΠ ΠΠΠ‘ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ (ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΈ Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ) Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ (Π₯ΠΠ‘) ΠΈ Π² ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΠΌΠ΅ΡΠΎΠ΄Π° Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π±Π΅Π»ΠΊΠ° N84 Π² ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΡΠ΅Π» (ΠΠΠ). ΠΠ»Ρ Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ ΡΠ΅Π»ΠΈ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π»ΠΎΡΡ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ»Π΅Π΄ΡΡΡΠΈΡ Π·Π°Π΄Π°Ρ:
1. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π³Π΅Π½ΠΎΠΌΠ½ΡΡ ΠΈ Π°Π½ΡΠΈΠ³Π΅Π½ΠΎΠΌΠ½ΡΡ ΡΠ΅ΠΏΠ΅ΠΉ Π ΠΠ ΠΠΠ‘ Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ°Ρ ΠΊΡΠΎΠ²ΠΈ, Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠ°Π·Π½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ ΠΈ ΡΡΠ°Π΄ΠΈΡΠΌΠΈ Π₯ΠΠ‘.
2. ΠΡΠΎΠ²Π΅ΡΡΠΈ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ ΡΠ°ΡΡΠΎΡΠΎΠΉ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π ΠΠ ΠΠΠ‘ ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°.
3. ΠΠΎΠ»ΡΡΠΈΡΡ Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌΠ½ΡΠ΅ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠ΅ Π»ΠΈΠ½ΠΈΠΈ, ΠΏΡΠΎΠ΄ΡΡΠΈΡΡΡΡΠΈΠ΅ ΠΠΠ ΠΊ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠΌΡ Π±Π΅Π»ΠΊΡ N84 ΠΠΠ‘.
4. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΠΠΠ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΎΠ²Π°ΡΡ Ρ Π½Π°ΡΡΡΠ°Π»ΡΠ½ΡΠΌ Π°Π½ΡΠΈΠ³Π΅Π½ΠΎΠΌ N84 Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘.
ΠΠΠ£Π§ΠΠΠ― ΠΠΠΠΠΠΠ Π ΠΠ ΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ― Π¦ΠΠΠΠΠ‘Π’Π¬.
1. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅ΠΏΠΈ Π ΠΠ (ΠΏΠ»ΡΡ-Π ΠΠ) ΠΠΠ‘ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ Π²ΡΡΠ²Π»ΡΡΡΡΡ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ, ΡΠ΅ΠΌ Π² ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ (Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΈ Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ) Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘. ΠΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅ΠΏΠΈ (ΠΌΠΈΠ½ΡΡ-Π ΠΠ) ΠΠΠ‘ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Ρ Π² ΡΠΊΠ°Π½ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ Π½Π΅ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Ρ Π² Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘.
2. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π΅ΡΡΡ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΌΠΈΠ½ΡΡ-Π ΠΠ ΠΠΠ‘, ΡΡΠΎ ΠΌΠΎΠΆΠ΅Ρ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΠΎΠ²Π°ΡΡ ΠΎ ΠΏΠΎΠ΄Π°Π²Π»Π΅Π½ΠΈΠΈ ΡΠ΅ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΠΈ Π²ΠΈΡΡΡΠ° ΠΏΡΠΈ ΡΠ΅ΡΡΠ΅Π·Π½ΡΡ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΏΡΠΎΡΠ΅ΡΡΠ°Ρ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ.
3. Π ΠΏΠ΅ΡΠ΅Π½ΠΈ ΡΠ°ΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½Π° Π ΠΠ ΠΠΠ‘ ΠΏΡΠΈ ΠΎΡΡΡΡΡΡΠ²ΠΈΠΈ ΡΡΠΎΠ³ΠΎ ΠΌΠ°ΡΠΊΠ΅ΡΠ° Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅, ΡΡΠΎ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π²ΠΈΡΡΡΠ½ΠΎΠΉ Π ΠΠ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ.
4. ΠΠΎΠ»ΡΡΠ΅Π½Π° ΠΏΠ°Π½Π΅Π»Ρ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΡΠ΅Π», Π²ΡΡΠ²Π»ΡΡΡΠΈΡ 5 ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΡ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°Π½Ρ Π½Π΅ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° N84 ΠΠΠ‘.
5. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½ ΠΌΠ΅ΡΠΎΠ΄ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π±Π΅Π»ΠΊΠ° N84 ΠΠΠ‘ Π² ΠΊΡΠΈΠΎΡΡΠ°ΡΠ½ΡΡ ΡΡΠ΅Π·Π°Ρ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΡΠ΅Π».
ΠΠ‘ΠΠΠΠΠ«Π ΠΠΠΠΠΠΠΠΠ―, ΠΠ«ΠΠΠ‘ΠΠΠ«Π ΠΠ ΠΠΠ©ΠΠ’Π£.
1. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΡΠ°ΡΡΠΎΡΠ° Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π ΠΠ ΠΠΠ‘ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½Π° Π² ΡΠΊΠ°Π½ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π½ΠΈΠΆΠ΅ Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘.
2. Π Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ Π°Π½ΡΠΈΠ³Π΅Π½ΠΎΠΌΠ½Π°Ρ ΡΠΎΡΠΌΠ° Π ΠΠ ΠΠΠ‘ Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½Π°.
3. ΠΠΎΠ»ΡΡΠ΅Π½ΠΎ 6 Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌ, ΠΏΡΠΎΠ΄ΡΡΠΈΡΡΡΡΠΈΡ ΠΠΠ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠ΅ ΠΊ ΠΏΡΡΠΈ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΠΌ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°Π½ΡΠ°ΠΌ Π±Π΅Π»ΠΊΠ° N84 ΠΠΠ‘.
4. ΠΠΎΠΊΠ°Π·Π°Π½Π° ΠΏΡΠΈΠ½ΡΠΈΠΏΠΈΠ°Π»ΡΠ½Π°Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° N84 Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ Π‘ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΠΠΠ.
ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«.
ΠΠ«ΠΠΠΠ«.
1. ΠΠ· 87 ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ Π‘ (Π₯ΠΠ‘) ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅ΠΏΠΈ Π ΠΠ (ΠΏΠ»ΡΡ-Π ΠΠ) Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ (ΠΠΠ‘) Π²ΡΡΠ²Π»Π΅Π½Ρ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ’-ΠΠ¦Π Ρ 82% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ, Ρ 66% Π² Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΈ Ρ 54% Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½Π° ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠ²Π½Π°Ρ ΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠ΅ΠΌ ΠΏΠ»ΡΡ-Π ΠΠ ΠΠΠ‘ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ Π°Π»Π°Π½ΠΈΠ½Π°ΠΌΠΈΠ½ΠΎΡΡΠ°Π½ΡΡΠ΅ΡΠ°Π·Ρ (ΠΠΠ’) Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ. ΠΠ΅ΠΆΠ΄Ρ ΠΈΠ½Π΄Π΅ΠΊΡΠΎΠΌ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ (ΠΠΠ) ΠΈ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΈΠ½Π΄Π΅ΠΊΡΠΎΠΌ ΡΠΊΠ»Π΅ΡΠΎΠ·Π° (ΠΠΠ‘) ΠΈ ΡΠ°ΡΡΠΎΡΠΎΠΉ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠ»ΡΡ-Π ΠΠ ΡΠ²ΡΠ·ΠΈ Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ.
2. ΠΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅ΠΏΠΈ Π ΠΠ ΠΠΠ‘ (ΠΌΠΈΠ½ΡΡ-Π ΠΠ) Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ, Π² ΡΡΠ΅Π΄Π½Π΅ΠΌ, Ρ 32% Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘. Π§Π°ΡΡΠΎΡΠ° Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΌΠΈΠ½ΡΡ-Π ΠΠ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π΅Ρ ΠΏΡΠΈ ΠΏΠ΅ΡΠ΅Ρ ΠΎΠ΄Π΅ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Ρ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ (ΠΠΠ=1−3) Π² Π³Π΅ΠΏΠ°ΡΠΈΡ ΡΠΎ ΡΠ»Π°Π±ΠΎΠ²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ (ΠΠΠ=4−8) ΠΎΡ 12 Π΄ΠΎ 42% ΠΈ ΡΠΌΠ΅Π½ΡΡΠ°Π΅ΡΡΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ Π₯ΠΠ‘ (ΠΠΠ=9−12) Π΄ΠΎ 17%.
3. Π Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π₯ΠΠ‘ Π½Π΅ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΎ ΠΌΠ°ΡΠΊΠ΅ΡΠ° Π°ΠΊΡΠΈΠ²Π½ΠΎΠΉ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΠΈ (ΠΌΠΈΠ½ΡΡ-Π ΠΠ) ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠΈ Π² ΡΡΠΈΡ ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΡ ΡΠ΅ΠΏΠ΅ΠΉ Π ΠΠ Π²ΠΈΡΡΡΠ°.
4. ΠΠ»Ρ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ Π ΠΠ ΠΠΠ‘ Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ, Π½ΠΎ ΠΈ Π² ΠΏΠ΅ΡΠ΅Π½ΠΈ.
5. ΠΠΎΠ»ΡΡΠ΅Π½ΠΎ 6 Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠΌ, ΠΏΡΠΎΠ΄ΡΡΠΈΡΡΡΡΠΈΡ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° (ΠΠΠ) ΠΊ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠΌΡ Π±Π΅Π»ΠΊΡ N84 ΠΠΠ‘. ΠΡΠΈ ΠΠΠ ΠΎΠΏΠΎΠ·Π½Π°ΡΡ ΠΏΡΡΡ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΡ ΡΠΏΠΈΡΠΎΠΏΠΎΠ²: ΠΎΠ΄ΠΈΠ½ Π»ΠΈΠ½Π΅ΠΉΠ½ΡΠΉ ΡΠΏΠΈΡΠΎΠΏ Π² ΠΎΠ±Π»Π°ΡΡΠΈ 1700−1707 Π°.ΠΎ. (ΠΠΠ ΠΠ1 ΠΈ ΠΠ2), Π΄Π²Π° Π»ΠΈΠ½Π΅ΠΉΠ½ΡΡ ΡΠΏΠΈΡΠΎΠΏΠ° Π² ΠΎΠ±Π»Π°ΡΡΠΈ 1711−1732 Π°.ΠΎ. (ΠΠΠ Π¨Π ΠΈ Π¨11), ΠΈ Π΄Π²Π° ΠΊΠΎΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎ-Π·Π°Π²ΠΈΡΠΈΠΌΡΡ ΡΠΏΠΈΡΠΎΠΏΠ°, ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΡΡ Π² ΡΠ°ΠΉΠΎΠ½Π΅ 1689−1738 Π°.ΠΎ. (ΠΠΠ Π‘1) ΠΈ 1677−1756 Π°.ΠΎ. (ΠΠΠ 6Π11).
6. ΠΠΠ ΡΠΏΠΎΡΠΎΠ±Π½Ρ Π²ΡΡΠ²Π»ΡΡΡ Π½Π°ΡΡΡΠ°Π»ΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ N84 Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΠΏΠ΅ΡΠ΅Π½ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠΎΠΌ Π‘. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΡΡΡ Ρ Π±Π΅Π»ΠΊΠΎΠΌ N84, Π»ΠΎΠΊΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎΠΌ Π² ΡΠΈΡΠΎΠΏΠ»Π°Π·ΠΌΠ΅ Π·Π°ΡΠ°ΠΆΠ΅Π½Π½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ, ΠΠΠ 6Π11, Π¨11 ΠΈ ΠΠ 12.
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°Π»Π°ΡΠ½ Π.Π‘., ΠΠΈΡ Π°ΠΉΠ»ΠΎΠ² Π. Π. ΠΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΠΎΠ²Π°ΡΡ -Π²ΠΈΡΡΡΠ½ΡΠ΅ Π³Π΅ΠΏΠ°ΡΠΈΡΡ. ΠΠ·Π΄. 2-Π΅. Π.: ΠΠΌΠΈΠΏΡΠ΅ΡΡ. 1999. — 304 Ρ.
- ΠΠ°ΠΌΠΈΠ½ΡΠΊΠΈΠΉ Π.Π‘. Π‘ΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ . ΠΠ΅Π½ΠΈΠ½Π³ΡΠ°Π΄ΡΠΊΠΎΠ΅ ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅: ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°. — 1964. -252Ρ.
- ΠΠΎΠΏΠ°ΡΠΊΠΈΠ½Π° Π’.Π. ΠΠ»ΠΈΠ½ΠΈΠΊΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘. // ΠΠΈΡΡΡΠ½ΡΠ΅ Π³Π΅ΠΏΠ°ΡΠΈΡΡ: Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ ΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ. 1997. -N1. — Π‘. 12−16.
- ΠΡΠ²ΠΎΠ² Π.Π. ΠΠΈΡΡΡΠ½ΡΠΉ Π³Π΅ΠΏΠ°ΡΠΈΡ Π‘ «Π»Π°ΡΠΊΠΎΠ²ΡΠΉ ΡΠ±ΠΈΠΉΡΠ°». // Π ΠΎΡΡ, Π³Π°ΡΡΡΠΎΡΠ½ΡΠ΅ΡΠΎΠ». ΠΆΡΡΠ½Π°Π». — 1995. -N1. — Π‘.4−6.
- ΠΠ°ΠΉΡΠ΅ΡΡΠ½ Π.Π‘., ΠΡΠ΄ΡΡΠ²ΡΠ΅Π²Π° Π. Π., ΠΡΠ΄ΡΡΠ²ΡΠ΅Π² Π. Π. Π¦ΠΈΡΠΎΡΠ»ΡΠΎ-ΡΠΈΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π³Π»ΠΈΠΊΠΎΠ³Π΅Π½Π° Π² ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΡΡΡΠΈΡ ΠΈ Π½Π΅ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΡΡΡΠΈΡ ΠΠΠ Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠ°Ρ ΡΠ΅Π³Π΅Π½Π΅ΡΠΈΡΡΡΡΠ΅ΠΉ ΠΏΠ΅ΡΠ΅Π½ΠΈ. // Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ. 1983. — Π’. 25. — N5. -Π‘. 546−551.
- ΠΠΈΠΌΠ΅Π½ΠΎΠ² Π.Π., ΠΡΠ±ΠΎΠ² Π‘. Π., ΠΠΎΠ»ΠΎΠ±ΠΎΠ² A.A. ΠΈ Π΄Ρ. ΠΠ½ΡΠΈΠ³Π΅Π½Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ΅ΠΏΡΠΈΠ΄ΠΎΠ², Π²ΠΎΡΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠΈΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΠ΅ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°Π½ΡΡ ΡΡΡΡΠΊΡΡΡΠ½ΡΡ ΠΈ Π½Π΅ΡΡΡΡΠΊΡΡΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² Π²ΠΈΡΡΡΠ° Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘. // ΠΠΈΠΎΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΡ. 1998. — N3. — Π‘.76−81.
- Π‘ΠΎΡΠΈΠ½ΡΠΎΠ½ Π‘.Π. ΠΠΈΡΡΡΠ½ΡΠ΅ Π³Π΅ΠΏΠ°ΡΠΈΡΡ. ΠΠ·Π΄. 2-Π΅. Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³: Π’Π΅Π·Π°.- 1998.-331 Ρ.
- Adinolfi L.E., Andreana A., Utili R. et al. HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis Π‘ patients and their relationship to liver injury. // Am. J. Gastroenterol. 1998. — V.93. -N11.-P.2162−2166.
- Almeshari K., Alahdal M., Alfurayh O. et at. New inights into hepatitis Π‘ virus ifection of hemodialisis patients the implications. // Am. J. Kid. Dis.1995.-V. 25.-N4.-P. 572−578.
- Ballardini G., GroffP., Giostra F. et al. Hepatocellular codistribution of Π‘100, Π‘ΠΠ, C22, and NS5 hepatitis Π‘ virus antigens detected by using immunopurified polyclonal spontaneous human antibodies. // Hepatology. -1995. V. 21. — P.730−734.
- Ballardini G., Manzin A., Giostra F. et al. Quantitative liver parametrs of HCV infection relation to HCV genotypes, viremia and response to interferon treatment. // J. Hepatol. — 1997. — V.26. — N4. — P.779−786.
- Bartenschlager R., Ahlborn-Laake L., Mous G., Jacobsen H. Nonstructural protein 3 of the hepatitis Π‘ virus encodes a serine-type proteinase required for clevage at the NS¾ and NS4/5 junctions. // J. Virol.- 1993. -V.67.- P.3835−3844.
- Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen M. Kinetic and structural analyses of hepatitis Π‘ virus polyprotein processing. // J. Virol. -1994. Vol. 68. — N8. — P. 5045−5055.
- Bartenschlager R., Ahlborn-Laake L., Yasargil K. et al. Substrate determinants for clevage in cis and in trans by the hepatitis Π‘ virus NS3 proteinase. // J. Virol. 1995. — V.69. — P. 198−205.
- Bartenschlager R., Lohmann V. Replication of hepatitis Π‘ virus. // J. Gen. Virol. 2000. — V.81. — P. l631 -1648.
- Behrens S., Tomei L., De Francesco R. Identification and properties of the RNA-depended RNA polymerase of hepatitis C virus. //EMBO Journal. 1996. — V.15. — P. 12−22.
- Bellentani S., Pozzato G., Saccoccio G. et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. // Gut. 1999. — V.44. — N6. — P.874−880.
- Bhattacherjee N., Prescott L.E., Pike I. et al. Use of NS-4 peptides to identifity type-specific antibody to hepatitis C virus genotypes 1, 2,3,4,5 and 6. // J.Gen.Virol. 1995. — V.76. — P. 1737−1748.
- Blight K., Lesniewski R.R., Labrooy J.T. et al. Localisation of hepatitis C virus proteins in infected liver tissue by immunofluorescence. // J. Gen.Virol. -1993.-V.76.-P. 1737−1748.
- Blight K., Rowland R., Hall P. et al. Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology. // Amer. J. Pathol. 1993. — V.143. — P. 1568−1573.
- Blight K., Lesniewski R.R., Labrooy J.T., Gowans E.J. Detection and distribution of hepatitis C-specific antigens in naturally infected liver. // Hepatology. 1994. — V. 20. — P. 553−557.
- Booth J.C., Foster G.R., Levine T. et al. The relationship to genotype in chronic HCV infection. // Liver. 1997. — V.17. -N3. — P.144−151.
- Boyer N., Marcellin P. Natural history of hepatitis C and the impact of anti-viral therapy. // Forum (Genova). 2000. — V. 10. — N1. — P.4−18.
- Bozdayi A.M., Uzunalimoglu O., Asian N. et al. Influence of viral load and alanine aminotransferase on viral genetic heterogeneity in patients withchronic hepatitis C virus infection. // Intervirology. 2000. — V.43. -Nl. — P.6166.
- Brody R.I., Eng S., Melamed J. et al. Immunohistochemical detection of hepatitis C antigen by monoclonal antibody TORDJI-22 compared with PCR viral detection. //Am. J. Clin. Pathol. 1998. — V. l 10. — Nl. -P.32−37.
- Bukh J., Purcell R.H. Miller R.H. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected wordwide. // Proc. Natl. Acad. Sci. USA. 1993. — V.90. — P.8234−8238.
- Bukh J., Purcell R.H. Miller R.H. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. // Proc. Natl. Acad. Sci. USA. 1994. — V.91. -P.8239−8243.
- Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. // Semin. Liver Dis. 1995. — V.15. — P.41−63.
- Buti M., Esteban R. What to do when standart therapy fails. // Forum (Genova). 2000. — V. l0. — N1. — P.63−69.
- Castillo A., Suhira M.L., Civeira M.P., Prieto J. Correlation between lymphocyte and monocyte function in patients with chronic non-A, non-B hepatitis letter. // Am. J. Gastroenterol. 1989. — V.84. — P.978−982.
- Cerino A., Mondelli M. Identification of immunodominant B-cell epitope on the hepatitis C nonstructural region definded by human monoclonal antibodies. // J. Immunol. 1991. — Vol. 147. — N4. — P. 2692−2696.
- Chamberlain R.W., Adams N.J., Taylor L.A. et al. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. // Biochem. Biophys. Res. Commun. 1997. — V.236. — P.44−49.
- Chamlian A., Benkoel L., Sahel J. et al. Immunohistochemical detection of hepatitis C virus related CI00−3 and core antigens in formalin-fixed liver tissue. // Cell.Molec. Biology. 1996. — V. 42. — P. 557−566.
- Chang J.C., Seidel C., Ofenloch B. et al. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides. // Virology. -1999. V. 257.-P. 177−190.
- Chang M., Marquardt A.P., Wood B.L. et al. In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. // J. Virol. 2000. — V.74. — N2. — P.944−955.
- Chen D., Kuo G., Sung J. et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease- the faiwan experience. // J. Infect. Dis. 1990. — V. 162. — P.817−822.
- Chen C.-M., You L.-R., Hwang L.-H. Lee Y.-H. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-(3 receptor modulates the signal pathway of the lymphotoxin-P receptor. // J.Virol. 1997. -V.71.-P.9417−9426.
- Chen ML, Sallberg M., Sonnerborg A. et al. Human and murine antibody recognition is focused on the ATP/helicase, but not the protease domain of hepatitis C virus nonstructural 3 protein. // Hepatology. 1998. — V.28. — P.219−224.
- Chen M., Sallberg M., Sonnerborg A. et al. Limited humoral immunity in hepatitis C virus infection. // Gastroenterology. 1999. — V. l 16. — P. 135−143.
- Cherman K.E. Alanine-aminotranspherase in clinical practice: review. // Arch. Intern. Med. -1991. V.151. -P.260−265.
- Chien D., Choo Q.-L., Ralston R. et al. Persistence of HCV dispite antibodies to both putative envelope glycoproteins. // Lancet. 1993. — V.342. -P.933.
- Cho S.W., Hwang S.G., Han D.S. et al. In situ detection of hepatitis C virus RNA in liver tissue using a digoxigenin-labeled probe created during a polimerase chain reaction. // J. Med. Virol. 1996. — V.48. -N3. -P.327−333.
- Chomezynski P., Sacchi N. Single step metod of RNA isolation by acid guanidium thiocyanate-phenol-chlorophorm extraction. // Analyt. Biochem. -1987. V.162. -P.156−159.
- Choo Q.-L., Kuo G., Weiner A.J. et al. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. // Science. 1989. -V.244. — P.359−361.
- Choo Q.-L., Weiner A.J., Overby L. et al. Hepatitis C virus: the major causative agent viral non-A, non-B hepatitis. // British. Med. Bull. 1990. -V.46. — P.423−441.
- Choo Q.-L., Richman J.H., Han K. et al. Genetic organization and diversity of the hepatitis C virus. // Proc. Natl. Acad. Sci. USA. 1991. — V.88. -P.2451−2455.
- De Francesco R., Urbani A., Nardi M.C. et al. A zinc binding site in viral serine proteinases. // Biochemistry. 1996. — V.35. — P.13 282−13 287.
- De Francesco R. Molecular virology of the hepatitis C virus. // J. Hepatol. 1999.- V.31.-N1.-P 47−53.
- De Moliner L., Pontisso P., De Salvo G.L. et al. Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. // Gut. 1998. — Y.42. — N5. — P.856−860.
- Del Porto P., Puntoriero G., Scotta C et al. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment. // Virology. 2000. -V.269. — N2. — P.313−324.
- Desmet V.J., Gerber M., Hoofnagle J.H. et al. Classification of chronic hepatitis: diagnosis, grading arid staging. // Hepatology. 1994. — V.19. -P. 1513−1520.
- Di Martino V., Saurini F., Samuel D. et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. // Hepatology. 1997. — V.26. — N5. — P.1343−1350.
- Diepolder H.M., Zachoval K., Hoffman R.M. et al. Possible mechanism involving T lymphocyte to response to non-structural protein 3 in viral clearance in acute hepatitis C infection. // Lancet. 1995. — V.346. — P. 10 061 007.
- Diepolder H.M., Gerlach J.T., Zachoval K. et al. Immunodominant CD4+ T cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. // J. Virol. 1997. — V.71. — P.6011−6019.
- Doughty A.L., Painter D.M., McCaughan G.W. Nonspecificity of monoclonal antibody Tordji-22 for the detection of hepatitis C virus in liver transplantant recipients with cholestatic hepatitis. // Liver Transpl. Surg. 1999. -V.5. — N1. — P.40−45.
- Dries V., von Both I., Muller M. et al. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. // Hepatology.- 1999. V.28. — N1.-P.223−229.
- Dubuisson J., Hsu H., Cheung R. et al. Formation and intracellular localization of hepatitis C virus invelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses.//J. Virol. 1994. — Vol. 68. — N10. — P.6147−6160.
- Dubuisson J., Rice C.M. Hepatitis C virus glycoprotein folding: disulfide bond formation and assotiation with calnexin. // J. Virol. 1996. — V.70. -P.778−786.
- Enomoto N., Kurosaki M., Tanaka Y. et al. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. // J. Gen. Virol. 1994. -Vol. 75.-N2.-P. 1361−1369.
- Esteban R. Epidemiology of hepatitis C virus infection. // Abstr. Internat. Symp. on Viral Hepatitis and Liver Disease. Houston. 1990. — P. 160.
- Esteban J.I., Genesca J., Alter H.J. Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention. // Progr. Liv. Dis.- 1992. N10. — P.253−282.
- Fan X., Solomon H., Poulos J.E. et al. Comparison of genetic heterogeneity of hepatitis C viral RNA in liver tissue and serum. // Am. J. Gastroenterol. 1999. — V.94. -N5. — P. 1347−1354.
- Farci P., Alter H.J., Wong D. et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. // N. Eng. J. Med. 1991. — V.325. -P.98−104.
- Farci P., Alter HJ., Govindarajan S. et al. Lack of protective immunity against reinfection with hepatitis C virus. // Science. 1992. — V.258. — P.135−140.
- Feray C., Samuel D., Thiers V. et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. // J. Clin. Invest. 1992. — V.89. -P. 13 611 366.
- Ferrari E., Wright M.J., Fang J.W. et al. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. // J. Virol. 1999. — V.73. — P. 1649−1654.
- Forns X., Bukh J. Methods for determining the hepatitis C virus genotype. // Viral Hepatitis. 1998. — V.4. — N1. — P. 1 -19.
- Fournillier-Jacob A., Cahour A., Escriou N. et al. Processing of the El glycoprotein of hepatitis C virus expressed in mammalian cells. // J. Gen. Virol.- 1996. Vol. 77. — N5. — P. 1955−1964.
- Francis B., Ball V., Lee S. et al. Earlier detection of antibody to hepatitis C virus in seroconverters by Ortho second generation HCV assay. // Symposium on HCV. Los-Angeles. — 1990. — V. 16. — P. 103.
- Franco F., Mele A., Caprilli F. et al. Anti-HCV prevalence in outpatients attending a sexual transmitted disease clinic in Italy. // Abstr. Internal Symp. on Viral Hepatitis and Liver Disease. Houston. 1990. — P. 156.
- Gale M. Jr., Biakely C.M., Kwieciszewski B. et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. // Mol. Cell. Biol. 1998. — V.18. — P.5208−5218.
- Gastaldi M., Massacrier A., Plannels R. et al. Detection by in situ gybridization of hepatitis C virus positive and negative RNA strands using digoxigenin-labeled cDNA probes in human liver cells. // J. Hepatol. 1995. -V.23. — N5. — P.509−518.
- Gil B., Quian C., Riezu-Boj J.I. et al. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. // Hepatology. 1993. — V.18. — P. 1050−1054.
- Gerber M.A.Chronic hepatitis C: the beginning of the end of a time — honoured nomenclature? // Hepatology. 1992. — V.15. — N4. — P.733−734.
- Goeser T., Muller H.M., Jin Y.E. et al. Characterization of antigenic determinants in the core antigen of the hepatitis C virus. // Virology. 1994. -V.205. — P.462−469.
- Gonzalez-Peralta R. P., Fang J. W., Davis G. L. et al. Optimization for the detection of hepatitis C virus antigens in the liver. // J. Hepatol. 1994. — V. 20. -P. 143−147.
- Gonzalez-Peralta R.P., Fang J., Gary L. et al. Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C. // Dig. Dis. Sci. -1995.-V. 40.-P. 2595−2601.
- Gosalvez J., Rodriguez-Inigo E., Ramiro-Dias J. et al. Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. // Hepatology. 1998. — V.27. — N5. — P. 1428−1434.
- Grassi G., Pozzato G., Moretti M., Giacca M. Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. // J. Hepatol. 1995. — V.23. — N4. — P.403−412.
- Gretch D.R., Corey L., Wilson J. et al. Acessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. // J. Infect. Dis. 1994. -V.169. — P. 1219−1225.
- Gretch D.R., Bacchi C.E., Corey L. et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. // Hepatology. 1995. — V.22. — P. l-9.
- Guido M., Rugge M., Thung S.N. et al. Hepatitis C virus serotypes and liver pathology. // Liver. 1996. — V.16. — N6. — P.353−357.
- Gutfreund K.S., Bain V.G. Chronic viral hepatitis C: management update. // CMAJ 2000. — V.162. — N6. — P.827−833.
- Haydon G.H., Yarvis L.M., Blair C.S. et al. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. // Gut. 1998. — V.42. — N4. — P.570−575.
- Hellen C.U.T., Pestova T.V. Translation of hepatitis C virus RNA. // J. Viral. Hepat. 1999. — V.6. — PP.79−87.
- Hijikata M., Kato N., Ootsuyama Y. et al. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. 11 Proc. Nat. Acad. Sci. USA. 1991. — V.88. -P.5547−5551.
- Hijikata ML, Mizushima H., Tanji Y. et al. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. // Proc. Nat. Acad. Sci. USA. 1993. — V.90.-P. 10 773−10 777.
- Hirota M., Satoh S., Asabe S. et al. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation. // Virology. 1999.-V.257.-N1.-P.130−137.
- Irwing W., Creme E., Ho W. et al. Hepatitis C infection in anteantes and sexual health clinic patients in Australia: evidence for sexual transmission. // Abstr. VII Internat. Congr. Virol. Berlin. 1990. — P.38.
- Ishii K., Rosa D., Watanabe Y. et al. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. // Hepatology. 1998. — V.28. — P. l 117−1120.
- Ito T., Mukaigawa I., Hirabayaschi Y. et al. Cultivation of hepatitis C virus in primari hepaticyte culture from patients with chronic hepatitis C virus in release of high titre infectious virus. // J. Gen. Virol. 1996. — Vol. 77. -N5.-P. 1043−1054.
- Jamal M.M., Soni A., Quinn P.G. et al. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwesten United States. // Hepatology. 1999. — V.30. — N5. -P.1307−1311.
- Jolivet-Reynaud C., Dalbon P., Viola F. et al. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection. // J. Med. Virol. 1998. — V.56. — N4. — P.300−309.
- Kage M., Shimamatu K., Nakashima E. et al. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. // Hepatology. 1997. — V.25. -P.1028−1031.
- Khudyakov Y.E., Khudyakova N.S., Jue D.L. et al. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides // Virology. 1995. — V.206. — P.666−672.
- Kim D.W., Kim J., Gwack Y. et al. Mutational analysis of the hepatitis C virus RNA helicase. // J.Virol. 1997. — V.71. — P.9400−9409.
- Kim J.E., Song W.K., Chung K.M. et al. Subcellular localization of hepatitis C viral proteins in mammalian cells. // Arch. Virol. 1999. — V.144. -N2. -P.329−343.
- Kita H., Hiroishi K., Moriyama T. et al. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. // J. Gen.Virol. 1995. -V.76. — P.3189−3193.
- Kobayashi M., Tanaka E., Matsumoto A. et al. Antibody response to E2/E1 hepatitis C virus protein in patients with acute hepatitis C. // J. Gastroenterol. Hepatol. 1997. — V.12. — P.73−76.
- Kobayashi K., Ishii M., Igarashi T. et al. Profiles of cytokines produced by CD4-positive Y lymphocytes stimulated by anti-CD3 antubody in patients with chronic hepatitis C. // J. Gastroenterol. 1998. — V.33. — P.500−507.
- Koch J.O., Bartenschlager R. Modulation of hepatitis C virus NS5A hyperphophorylation by nonstructural proteins NS3, NS4A, and NS4B. // J. Virol. 1999. — V.73. -N9. — P.7138−7146.
- Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predifmed specificity. // Nature. 1975. — V. 256. — P. 495−497.
- Kolykhalov A.A., Feinstone S.M., Rice C.M. Identification of highly conserved sequence element at the 3'-terminus of hepatitis C virus genome RNA. // J. Virol. 1996. — V.70. — N6. — P.3363−3371.
- Koziel M.J., Walker B.D. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C infection. // Springer Semin. Immunopatol. 1997. — V.19. -P.69−83.
- Krawczynski K., Beach M.J., Bradly D.W. et al. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. // Gastroenterology.- 1992. Vol. 103. — N5. — P. 622−629.
- Lam N.P. Hepatitis C: natural history, diagnosis, and management. // Am. J. Health. Syst. Pharm. 1999. — V.56. -N10. — P.961 — 973.
- Larghi A., Tagger A., Crosignani A. et al. Clinical significance of hepatitis C HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interpheron-alpha therapy. // J. Med. Virol. 1998. -V.55. -Nl. -P.7−11.
- Laskus T., Radkowski M., Wang L.F. et al. Lack of evidence of hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. // J. Virol. 1997. — V.71. — N10. — P.7804−7806.
- Lau G.K.K., Fang J.V.C., Wu P. S. et al. Detection of hepatitis C viru s genome in formalin-fixed parafin-embedded liver tissue by in situ reverse transcription polymerase chane reaction. // J. Med. Virol. 1994. — V.44. — N5.- P.406−409.
- Lee J.W., Kim K.-M. Jung S.-H. et al. Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies. // J. Virol. 1999. — V.73. — N1. — P. 11−18.
- Leevy C.B., Zierer K.G., Leevy C.M. Viral hepatitis C. // J. Assoc. Acad. Minor. Phys. 1998. — V.9. — N4. — P.59−64.
- Lelie P.N., Damen M., Cuypers H. et al. International collaborative study on the second eurohep HCV-RNA reference panel. // J. Virol. 1996. — Vol. 81.- N1. P.347−352.
- Lerat H., Berby F., Trabaud M.A. et al. Specific detection of hepatitis C minus strand RNA in hematopoetic cells. // J. Clin. Invest. 1996. — V.97. — N3. -P.845−851.
- Lin C., Lindenbach B.D., Pragai B.M. et al. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with diffirent C-termini. // J. Virol. 1994a. — Vol. 68. — N8. — P. 5063−5073.
- Lin C., Pragai B.M., Grakoui A. et al. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. // J. Virol. -19 946. Vol. 68. — N12. — P. 8147−8157.
- Lo S.-Y., Masiarz F., Hwang S.B. et al. Differencial subcellular localization of hepapitis C virus core gene products. // Virology. 1995. -Vol.213. — N4.-P. 456−461.
- Lo S.-Y., Selby M.J., Ou J.-H. Interaction between hepatitis C virus core protein and El envelope protein. // J. Virol. 1996. — V.70. — P.5177−5182.
- Lohr H.F., Schlaak J.K. Kollmannsperger S. et al. Liver infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. // Liver. 1996. — V.16. — P. 174 182.
- Lu W., Lo S., Chen M. et al. Activation of p53 tumor supressor by hepatitis C virus core protein In Process Citation. // Virology. 1999. — V.264. — P.134−141.
- Luo G., Hamatake R.K., Mathis M.D. et al. De novo initiation of RNA synthesis by the RNA-depended RNA polymerase (NS5B) of hepatitis C virus. // J. Virol. 2000. — V. 74. — P.851 -863.
- Lvov D.K., Samokhvalov E.I., Tsuda F. et al. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. // Arch. Virol. -1996. -V. 141. P. 1613−1622.
- Mandelli M., Cristine G., Filice G. et al. Anti-HCV positive patients in dialysis units. // Lancet. 1990. — V.336. — P.244.
- Mangia A., Andriulli A., Zenarola P. et al. Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients. // J. Med. Virol. 1999. — V.59. -N3. — P.277−280.
- Manns M.P., Griffin K.J., Sullivan K.F. et al. LKM-1 autoantibodies recognaze a short linear sequence in P450IID6, a cytochrome P450 monooxygenase. // J. Clin. Invest. 1991. -V.88. — P. 1370−1378.
- Manzin A., Bagnarelli P., Menzo S. et al. Quantification of hepatitis C virus genome molecules in plasma samples. // J. Clin. Microbiol. 1994. -V.32.-N8. -P.1939−1944.
- Marcellin P. Hepatitis C: clinical spectrum of the disease. // J. Hepatol. -1999. V.31. — N1. — P.9−16.
- Markis M., Preston F., Triger D. et al. Hepatitis C antibody and chronic liver disease in haemophilia. // Lancet. 1990. — V.335. — P. l 117−1119.
- Martin J., Navas S., Quiroga J.A. et al. Quantification of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection. // J. Med. Virol. 1998. — V.54. -N4. — P.265−270.
- Masalova O.V., Atanadze S.N., Samokhvalov E.I. et al. Detection of hepatitis C virus core protein circulating within different virus particle population. // J. Med. Virol.- 1998. V.55. — P. 1−6.
- Matsumoto M., Hwang S.B., Jeng K.-S. et al. Homotypic interaction and multimerization of hepatitis C virus core protein. // Virology. 1996. — Vol. 218. — N3. — P. 43−51.
- Mayo M.A., Pringle C.R. Virus taxonomy 1997. // J. Gen. Virol. -1998. — V.79. — P.649−657.
- Mazzella G., Accogli E., Sottili S. et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrosis. // J. Hepatol. -1996. V.24. -PP.141−147.
- Mc Gornick S.E., Goodman Z.D., Maydonovitch C.L., Sjogren M.H. Evaluation of liver histology, ALT elevation and HCV RNA titer in patients with chronic hepatitis C. //Amer. J. Gastroenterol. 1996. — V.91. — N8. -P. 1516−1523.
- Mc Guinnes P.H., Bishop G.A., Painter D.M., Chan R. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. // Hepatology. 1996. — V.23. — N4. — P.676−687.
- Mc Kechnie V.M., Mills P.R., Mc Gruden E.A. The NS5a gene of hepatitis C virus in patients treated with interferon-alpha. // J. Med. Virol. -2000. V.60. — N4. — P.367−378.
- Mellor J., Haydon G., Blair C. et al. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus / GB virus C in peripheral blood mononuclear cells. // J. Gen. Virol. 1998. — V.79. — N4. — P.705−714.
- Mishiro S., Hoshi Y., Takeda K. Hepatitis C specific an-tibodies directed at host derived epitope implication for an au-toimmune process. // J. Virol.1994. Vol. 69. -N4. -P. 1400−1403.
- Mizokami M., Gojobori T., Ohba K.-I. et al. Hepatitis C virus types 7, 8 and 9 shoud be classified as type 6 subtypes. // J. Hepatol. 1996. — V.24. -P.622−624.
- Mizushima H., Mijikata M., Asabe S.-I. et al. Two hepatitis C virus glycoprotein E2 products with different C-termini. // J. Virol. 1994. — Vol.68. -N10.-P. 6215−6222.
- Moradpour D., Kary P., Rice C., Blum H.E. Continious human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. // Hepatology. 1998. -V. 28.-P. 192−201.
- Muratori B.L., Gibellini D., Lenzi M. et al. Quantification of hepatitis C virus infected peripheral blood mononuclear cells by in situ reverse transcriptase chain reaction. // Blood. 1996. — V.88. — N7. — P.2768−2774.
- Nagata I., Iizuka T., Harada Y. et al. Prospective study of mother to -infant transmission of hepatitis C virus. // Abstr. of 8-th Intern. Sympos. on Viral Hepatitis and Liver Dis., Tokyo. — 1993. — P.70.
- Nakajima N., Hijikata M., Yoshikura H., Shimizu Y. Characterization of long-term cultures of hepatitis C virus. // J. Virol. 1996. — V. 70. — N5. — P. 3325−3329.
- Nakane P.K., Kawaoi A. Peroxidase labelled antibody: a new method of conjugation. // J. Histochem. Cytochem. 1974. -V.22. — P. 1084−1091.
- Navas S., Bosch O., Castillo I. et al. Porphyria cutanea tarda and hepatitis C and hepatitis B viruses infection a retrospective study. // Hepatology.1995. V.21. — N2. — P.279−284.
- Nayak N.C., Sathar S.A. Immunohistochemical detection of hepatitis C virus antigen in paraffin embedded liver biopsies from patients with chronic liver disease. // Acta Histochem. 1999. — V. 101. — N4. — P.409−419.
- Negro F., Giostra E., Krawczynski K. et al. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: preliminary application to the liver transplantation model. // J. Hepatol. 1998. -V.29.-P.1−11.
- Nelson D.R., Marousis C.G., Davis G.L. et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. // J. Immunol. -1997. V. 158. — P. 1473−1488.
- Nelson D.R., Marousis C.G., Ohno T. et al. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. // Hepatology. 1998. — V.28. — P.225−230.
- Nemecek V., Fleglova Z.I., Suchankova A.V. Mapping of immunodominant epitopes in NS3/NS4 region of HCV by syntetic peptides. // J. Virol. 1993. -V. 52. — N7. — P. 185−190.
- Nikolaeva L.I., Olenina L.V., Kolesanova E.F. Immuniti of different types of hepatitis C. // Russ. J. Immunol. 1999. — V.4. — N2. — P.92−112.
- Nouri Aria K.T., Sallie R., Sangar D. et al. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. // J. Clin. Invest. 1993. — V.91. — N5. — P.2226−2234.
- Nouri-Aria K.T., Sallie R., Mizokami M. et al. Intrahepatic expression of hepatitis C virus antigens in chronic liver disease. // J. Pathol. 1995. — V.175. -P.77−83.
- Okabe M., Fukuda K., Arakawa K., Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. // Circulation. 1997. -V.96. — N1. — P.22−24.
- Okamoto H., Okada S., Sugiyama Y. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of praimers deduced from the 5'noncoding region. // Jap. J. Exp. Med. 1990. — V.60. — N3. — P.215−222.
- Okamoto M., Kojima M., Okada S.-I. et al. Genetic drift of hepatitis C virus during an 8,2 year infection in a chimpanzee: variability and stability. // Virology. 1992. — V.190. -N7. -P.894−899.
- Okumura A., Yoshioka K., Aiyama T. et al. Different constitution of hepatitis C virus population in peripheral blood mononuclear cells and plasma in patients with type C chronic liver disease. // Dig. Dis. Sci. 1998. — V.43. — N2. -P.377−383.
- Orito E., Mizokavi M., Tanaka T. et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C genotypes. // Gut. 1996. — V.39. — P.876−880.
- Osna N., Silonova G., Vilgert N. et al. Chronic hepatitis C: T helper 1/T helper 2 imbalance could cause virus persistence in peripheral blood. // Scand. J. Clin. Lab. Invest. 1997. — V.57. -PP.703−710.
- Peterson D.A., Johnson R.G., Nemo G. et al. Evaluation of TTVS specimens for antibodies to HCv by Abbot HCV EIA and a prototype second generation assay. // Second Int. Symposium on HCV. Los Angeles. — 1990. -V.26. -P.55.
- Pileri P., Uematsu Y., Campagnoli S. et al. Binding of hepatitis C virus to CD81. // Science. 1998. — V.282. -P.938−941.
- Pizzi E., Tramontano A., Tomei L. et al. Molecular model of the specificity pocket of the hepatitis C virus proteinase: implications for substrate recognition. // Proc. Natl. Acad. Sci. USA. 1994. — V.91. — P.888−892.
- Powell E.E., Edwards-Smith C.J., Hay J.L. et al. Host genetic factors influence disease progression in chronic hepatitis C. // Hepatology. 2000. -V.31. — N4. — P.828−833.
- Prince A.M., Brotoman B., Grady G.F. et al. Long-incubation posttransfusion hepatitis without serological evidence of exposure to hepatitis B virus. // Lancet. 1974. — V.2. — P.241−246.
- Prince H.E., Fang C.T. Unaltered lymphocyte subsets in hepatitis Cvirus-seropositive blood donors. // Transfusion. 1992. — V.32. — P.166−168.
- Prince A.M., Scheffel J.W., Moore B. et al. A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase. // Transfusion. 1997. — V.37. -P.211−214.
- Quiroga J.A., Martin J., Pardo M., Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relationship to therapeutic response to interferon-a. // Dig. Dis. Sci. 1994. — V.39. — P.2485−2496.
- Radkowski M., Kubicka J., Kisiel E. et al. Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. // Blood. 2000. — V. 95. — N12. — P.3986−3989.
- Rasenack I. Viral hepatitis diagnostics. Germany. — Falk Foundation.1993. -52p.
- Ray R., Khanna A., Lagging L.M. et al. Peptide immunogen mimicry of putative El glycoprotein-specific epitopes in hepatitis C virus. // J. Virol.1994. Vol. 68. — N7. — P. 4420−4426.
- Ray R., Lagging L.M., Meyer K. et al. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. // Virus Res.1995.- V.37. -P.209−220.
- Ray R., Steele R., Meyer K., Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. // J. Biol. Chem. 1997. — V.272. -P.10 983−10 986.
- Ray R., Steele R., Meyer K., Ray R. Hepatitis C virus core protein represses p21 WAFl/Cipl/Sidl promoter acyivity. // Gene. 1998. — V.208. -P.331−336.
- Robertson B., Myers G., Howard C. et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standartization. // Arch. Virol. 1998. — V.143. — N12. — P.2493−2503.
- Rodriguez-Inigo E., Bartolome J., de Lucas S. et al. Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. // Am. J. Pathol. 1999. — V.154. -N6.- P. 1877−1881.
- Ruster B., Zeuzem S., Roth W.K. Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript. // Anal. Biochem. 1995. — V.224. -P.597−600.
- Sacamuro D., Furukawa T., Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH3T3 cells. // J. Virol. 1995. — V. — 69. — N6. — P. 3893−3896.
- Saito K., Sullivan D., Haruna Y. et al. Detection of hepatitis C virus RNA sequences in hepatocellular carcinoma and its precursors by microdissection polymerase chain reaction. // Arch. Pathol. Lab. Med. 1997. — V. 121. — N4. -P.400−403.
- Sakugawa H., Nakasone H., Nakayoshi T. et al. Relation between reactivity to the NS4 region peptides of hepatitis C virus (HCV) and clinicalfeatures among patients infected with HCV genotype IB. // Microbiol. Immunol.- 1998.- V.42. P.299−303.
- Sallberg M., Pumpen P., Zhang Z.X. et al. Location of antibody-bin-ding sites within conserved regions of the hepatitis C virus core protein. // J. Med. Virol. 1994. — Vol. 43. -Nl. P. 62−68.
- Sanchez-Tapias J.M., Barrera J., Costa J. et al. Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. // Ann. Intern. Med. 1990. — V.112. — PP.921−924.
- Sansonno D., Dammacco F. Hepatitis C virus clOO antigen in liver tissue from patients with acute and chronic infection. // Hepatology. 1993. — V.18. -P.240−245.
- Sansonno D., Cornacchiulo V., Iacobelli A.R. et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. // Hepatology. 1995. — V.21. -P.305−312.
- Sansonno D., Iacobelli A.R., Cornacchiulo V. et al. Immunohistochemical detection of hepatitis C virus-related proteins in liver tissues. // Clin. Exp. Rheumatol. 1995. — V.13. — S29-S32.
- Sansonno D., Cornacchiulo V., Racanelli V., Damacco F. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-relatedantigenes in hepatocellular carcinoma. // Cancer. 1997. — V.80. -Nl. — P.2233.
- Santolini E., Migliaccio G., La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. // J. Virol. 1994. — V. 68. — N6. -P. 3631−3641.
- Sato K., Okamoto H., Aihara Sh. Demonstration of sugar moiety on the surface of hepatitis C virions recovered from circulation of infected humans. // Virology. 1993. -V.196. -N3. -P. 354−357.
- Scmidt W.N., Wu P., Han J.-Q. et al. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cells fractions: plasma HCV RNA analysis underestimates circulating virus load. // J. Infect. Dis. 1997. — V.176.- P.20−26.
- Seidl S., Koenig B., Reinhardt G. et al. Higher detection rate of hepatitis G and C virus RNA in liver tissue than in serum of deceased injection drug users. // Int. J. Legal. Med. 1999. — V. l 12. — Nl. -P.35−38.
- Selby M.J., Choo Q.-L., Berger K. et al. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. // J. Gen. Virol. -1993. V.74. — P. l 103−1113.
- Sergi C., Goeser T., Otto G.F. et al. A rapid and highly specific technique to detect hepatitis C RNA in frozen section in liver. // J. Clin. Pathol. 1996. -V.49. — N3. — P.369−372.
- Shapiro C., Cannon R., Alter M. et al. Prevalence of antibody to hepatitis C virus in heterosexuals attending in clinic for sexually transmitted desease. // Abstr. Internat. Symp. on Viral Hepatitis and Liver Disease. Houston. 1990. -P.156.
- Sharara A.I., Hunt C.M., Hamilton J.D. Hepatitis C. // Ann. Intern. Med.- 1996. V.125. -P.658−668.
- Sherlock S., Dooley J. Diseases of the liver and biliary system. // Tenth Edition Blackwell Science. 1997. -P.289−296.
- Sherlock S. The hepatic flaviviridae: summary. I I J. Viral. Hepat. 1999.- V.l. P. l-5.
- Shih C.-M., Lo S.J., Miyamura T. et al. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. // J. Virol. 1993. — V.67. — P.5823−5832.
- Shimizu Y.K., Hijikata M., Iwamoto A. et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. // J. Virol. 1994. — V.68. — P. 1494−1500.
- Shindo M., Di Biscegln A.M., Akatsuka T. et al. The physical state of the negative strand of hepatitis C virus RNA in serum of patients with cronic hepatitis C. // Proc. Natl. Acad. Sci. USA. 1994. — Vol. 91. — N8. — P. 87 198 723.
- Shirai M., Okada H., Nishioka M. et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. // J. Virol. -1994. V.68. — N5. — P.3334−3342.
- Shiratori Y., Kato N., Yokosuka O. et al. Quantitative assays for hepatitis C virus in serum as predictors of long-term response to interferon. // J. Hepatol.- 1997. V.27. — P.437−444.
- Simmonds P., Mellor J., Sakuldamrongpanich T. et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. // J. Gen. Virol. 1996. -V.77. — P.3013−3024.
- Sonnerborg A., Zhang Z.X., Sallberg M. A cell-binding Arg-Gly-Asp sequence is present in close proximitly to the major linear antigenic region of HCV NS3. // Bioch. Bioph. Res. Commun. 1994. — Vol. 202. — N3. — P. 13 551 356.
- Srinivas R.V., Ray R.B., Meyer K., Ray R. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. // Virus Res. 1996. — 1996. — V.45. — P.87−92.
- Sugano M., Hayashi J., Joon S. et al. Quantification of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction. // J. Clin. Pathol. 1995. — V.48. — N8. -P.820−825.
- Suzuki R., Matsuura Y., Suzuki T. et al. Nuclear localization of the truncated hepatitis C virus core protein with its gydrophobic COOH-terminus deleted. // J. Virol. 1995. — V. 76. — N5. — P.53−61.
- Takahashi K., Okamoto H., Kishimoto S. et al. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. // J. Gen. Virol. 1992. — Vol. 73. — N5. — P. 667 672
- Taliani G., Badolato C., Lecce R. et al. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. // J. Med. Virol- 1995. V.7. — N9. — P. 16−22.
- Tanaka K., Kato N., Cho M.J., Shimotohno K. A novel sequence found at the 3' terminus of the hepatitis C virus genome. // Biochem. Bioph. Res. Commun. 1995. — V.215. -P.744−749.
- Tanaka K., Kato N., Cho M.J., Shimotohno K. Structure of the 3' terminus of the hepatitis C virus. // J. Virol. 1996. — V.70. — P.3307−3312.
- Tanji Y., Hijikata M., Saton S. et al. Hepatitis C virus-encoded nonstructural protein NS4A has versatil function in viral protein processing. // J. Virol. -1995. V. 69. — N3. — P. 1575−1581.
- Tanji Y., Kaneko T., Satoh S., Shimatoho K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. // J. Virol. 1995. — V. 69. — N6. -P. 3980−3986.
- Tokita H., Okamoto H., Tsuda F. et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth and ninth major genetic groups. // Proc. Natl. Acad. Sci. USA. 1994. — V.91. — P. 11 022−11 026.
- Tokita H., Okamoto H., Iizuka H. et al. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. // J. Gen. Virol. 1996. — V.77. -P.293−301.
- Tomei L., Failla C., Vitale R.L. et al. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 proteinase. // J. Gen. Virol. 1996. — V.77. — P.1065−1070.
- Tong M., Blatt L., Mc Hutchison J. Prediction of response during interferon alpha-2b therapy in chronic hepatitis C using viral and biochemical characteristics: a comparison. // Hepatology. 1997. — V.26. — P. 1640−1645.
- Trepo C., Alonso S., Li J.S. et al. Limitation of immunoserological and molecular diagnosis of hepatitis C. // Nuclear Med. Biol. 1994. — V.21. -N3. -P.419−431.
- Tsutsumi M., Urashima S., Takada A. et al. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis. // Hepatology. 1994. — V.19. -N2. — P.773−778.
- Van Doom L., Capriles J., Maertens G. et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. // J. Virol. 1995. -V.69. — N2. — PP.773−778.
- Wang C., Sarnow P., Siddqui A. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. // J. Virol. 1994. — V.68. — Nil. -PP.7301−7307.
- Wejstal R., Hermodsson S., Iwarson S. et al. Mother to infant transmission of hepatitis C virus infection. // J. Med. Virol. 1990. — V.30. -P.178−180.
- Wienhues U., Ihlenfeldt H.G., Seidel C. et al. Characterization of a linear epitope in the nonstructural region-4 of hepatitis C virus with reactivity to seroconversion antibodies. // Virology. 1998. — V. 245. — P. 281−288.
- Wolk B., Sansonno D., Krausslich H.G. et al. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. // J. Virol. 2000. -V.74. — N5. — P.2293−2304.
- Wong D.K.H., Dudley D.D., Afdhal N.H. et al. Liver-derived CTL in hepatitis C infection: breadth and specificity of responses in a cohort of persons with chronic infection. // J. Immunol. 1998. — V.160. — P. 1479−1488.
- Wright-Minogue J., Yao N., Zhang R. et al. Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors. // J. Hepatol. 2000. — V.32. — P.497−504.
- Yamaguchi K., Nishimura Y., Fukuoka N. et al. Hepatitis C virus antibodies in haemodialisis patients. // Lancet. 1990. — P.335.
- Yamschikov V. F., Compans R. W. Formation of the Flavi-virus envelope: role of the viral NS2B-NS3 protease. // J. Virol. — 1995. — V. 69. -N4.-P. 1995−2003.
- Yan B.-S., Tam M.H., Syu W.-J. Self-association of the C-terminal domain of the hepatitis-C virus core protein. // Eur. J. Biochem. 1998. -V.258. — PP.100−106.
- Yasui K., Wakita T., Tsukiyama-Kohara K. et al. The native form and maturation process of hepatitis C virus core protein. // J. Virol. 1998. — V.72. -N7. — PP.6048−6055.
- Young K.C., Chang T.T., Liou T.C., Wu H.L. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva. // J. Med. Virol. 1993.- V.41.-N1.-P.55−60.
- Zignego A.L., De Carli M., Monti M. et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. // J. Med. Virol. 1995. — V.47. — P.58−64.
- Zanella A., Conte D., Ptati D. et al. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. // Hepatology. 1995. — V.20. — N4. — P.913−917.
- Zhang Z.X., Sonnerborg A., Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein. // Clin. Exp. Immunol. 1994. — V. 98. -N3.-P. 382−387.